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ABSTRACT
Fibromyalgia syndrome (FMS) is a 
common form of non-inflammatory 
rheumatism within the general popu-
lation with symptoms often mimicking 
those of arthritis or muscle disorders. 
Arthralgic symptoms in the region of 
the hip are commonly mentioned by 
patients with FMS and one of the diag-
nostic trigger points for the condition is 
found around the greater trochanter. To 
date, no formal imaging studies using 
ultrasound (US) have been performed 
in FMS.
This study describes the correlation 
between clinical and US findings in pa-
tients presenting with primary FMS to 
rheumatology clinics. 
In the majority of the patients, no sig-
nificant pathological US abnormalities 
were detected.
Introduction
Fibromyalgia syndrome (FMS) is a 
common disorder within the general 
population with estimates of prevalence 
between 1–4% (1-2). The condition can 
be primary or secondary to other chron-
ic conditions, including rheumatoid ar-
thritis, osteoarthritis, connective tissue 
disorders and chronic infection (3-5). 
The underlying etiology of FMS is cur-
rently unknown and indeed views relat-
ing to the disorder can be quite contro-
versial within the medical community.
The hip is amongst several anatomical 
regions from which patients with FMS 
frequently derive pain. To date, no 
large population studies have been per-
formed estimating its exact prevalence 
(6). Classification criteria for FMS fo-
cus on the presence of tender points, 
also known as trigger points, and one 
such trigger point is found on the outer 
aspect of the greater trochanter (5, 7). 
In recent years, proposals to change the 
diagnostic criteria have been suggested, 
with less emphasis on the identification 
of such trigger points and more towards 
symptom-based diagnosis (8). 
In patients with FMS it is imperative to 
exclude alternative pathologies and this 
often involves imaging modalities to 
look for structural anomalies of the hip 
joint. US is being increasingly used as 
an effective tool to identify soft tissue 
and joint pathology in the hip region.
Our group have already described the 
advantages relating to the superiority 
of US to blind clinical examination of 
the hip region (9-11).
To our knowledge, this is the first for-
mal imaging study using ultrasound 
(US) to have been performed in FMS.
This study describes the correlation be-
tween clinical and US findings in pa-
tients presenting with primary FMS to 
rheumatology clinics. 
Methods
The study was conducted according to 
the Declaration of Helsinki and local 
regulations, and informed consent was 
obtained from all patients.
Patients
Patients who fulfilled the 1990 Ameri-
can College of Rheumatology criteria 
for FMS (7), and attending the out-pa-
tient clinics of the Rheumatology De-
partments involved in this multicentre 
study were consecutively recruited. 
Study design
All patients underwent a complete clin-
ical assessment by an expert rheuma-
tologist who recorded the presence/ab-
sence of pain/tenderness (by palpation 
and/or active or passive mobilisation 
of the hip). Moreover, the Lequesne 
questionnaire was used to estimate the 
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severity of hip impairment (12). Prior 
to the beginning of the study, sonogra-
phers reached a consensus on both the 
scanning technique to adopt and the 
pathological findings to detect. One 
sonographer for each centre performed 
the US examinations, blinded to pa-
tients’ clinical data.
The patients were placed in a supine 
position, with the hip joints in neu-
tral position. US was performed with 
a Logiq 9 machine (General Electrics 
Medical Systems, Milwaukee, WI) 
with a 6–8 MHz multi-frequency lin-
ear array transducer. A standardised 
longitudinal anatomic section plane 
along the neck of the femur was used 
to visualise the anterior capsule, in or-
der to detect US findings indicative of 
hip joint inflammation according to the 
EULAR guidelines for musculoskel-
etal ultrasound in rheumatology (13). 
A multiplanar scanning technique was 
adopted to confirm the presence of all 
pathological findings.
Sonographic measurements of enthe-
seal thickness were performed where it 
appeared maximal as in previous stud-
ies by the group (10, 11). The following 
anatomic sites were examined: hip joint, 
trochanteric bursa, ilio-psoas bursa, glu-
teus tendons, and ilio-psoas tendon.
Power Doppler assessments were car-
ried out according to the indications 
provided by Torp-Pedersen et al. (14). 
US image interpretation
Sonographic findings indicative of hip 
pathology were documented and re-
ported. For the detection of synovial 
fluid, synovial hypertrophy, bone ero-
sion and enthesopathy the US defini-
tions described by the OMERACT spe-
cial interest group (15) were adopted. 
The limit for normal hip dimension was 
defined according to Koski et al., with 
values ≥7 mm and a difference of 1 or 
more mm is suggestive of joint space 
widening (16). 
The presence of osteophytes was de-
fined by the detection of characteristic 
irregularities of the bone profile as de-
scribed in previous studies concentrat-
ing on osteoarthritis (17-21).
Results
A total of 64 patients were assessed. 
Basic patient demographic and clinical 
data of the study population are report-
ed in the Table I 
US examination of the hip joint re-
vealed evidence of minimal joint effu-
sion in 14% of cases, mostly correlating 
with the presence of hip pain. A bursae 
effusion was present in 9/64 (14%) pa-
tients. Other hallmark features of in-
flammatory hip joint disease including 
synovial hypertrophy, bone erosion and 
intra-articular Doppler signal were not 
seen.
The most common tendon to demon-
strate US pathology was the gluteus 
tendon.
Table II shows the relationship between 
clinical and US findings indicative of 
hip region pathology.
The results of the Lequesne question-
naire showed that a severe to extremely 
severe impairment was present in at least 
19/64 (29.7%) patients, while a normal 
value was found in only 11/64 (17.2%) 
of patients. US findings were poorly 
represented in the group with no impair-
ment (data derived from the Lequesne 
questionnaire), with only two patients 
Table I. Patient demographic and clinical data.
 Number of patients           64
 Gender (female/male)         40/24
 Age in years (range)     54.6 (23-81)
 Disease duration in months; mean (range)                 92.9 (6-360)
 Tender points (mean)                  12.3 (0-18)
 Lequesne score; mean (range)                      6.2 (0-17)
 Number of patients with current painful hip in at least one side (%)                  33 (52%) 
 Number of patients with history of painful hip in at least one side (%)                  38 (59%)
 Number of patients with no history of painful hip and no current painful hip (%)             19 (30%)
 Number of patients on NSAIDs (%)                        10 (16%)
 Number of patients on steroid therapy (%)                        6 (9%)
Table II. Relationship between sonographic and clinical findings. The presence of at least 
one clinical finding indicative of pain at hip level was used to compile the table.
              Clinical findings - Painful hip
  
   Presence Absence Total
 Sonographic  Joint effusion Presence 9 2 11
 findings  Absence 39 78 117
  Total 48 80 128
 
 Synovial hypertrophy Presence 0 0 0
  Absence 48 80 128
  Total 48 80 128
 
 Intra-articular power Presence 0 0 0 
 Doppler signal Absence 48 80 128
  Total 48 80 128
 
 Osteophytes Presence 15 25 40
  Absence 33 55 88
  Total 48 80 128
 
 Trochanteric bursitis Presence 5 4 9
  Absence 43 76 119
  Total 48 80 128
 
 Ilio-psoas bursitis Presence 0 2 2
  Absence 48 78 126
  Total 48 80 128
 
 Gluteus tendinopathy Presence 10 25 35
  Absence 38 55 93
  Total 48 80 128
 
 Ilio-psoas tendinopathy Presence 4 11 15
  Absence 44 69 113
  Total 48 80 128
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showing monolateral ilio-psoas tendino-
pathy and another couple monolateral 
osteophytes. Only four patients in the 
group of severe to extremely severe im-
pairment had negative US findings. 
Discussion
Pain in the hip region is a frequent 
complaint from patients suffering from 
FMS.
The hip region does contain one of the 
classical trigger points seen common-
ly in the condition. However, appar-
ently, there is no relationship between 
the Lequesne results and the number 
of positive tender points (only one of 
the Lequesne negative patients was 
also negative for tender points), with 
no significant differences for this item 
between the subgroup of impairment as 
shown by the Lequesne results, con-
firming the scarce utility of using ten-
der points to investigate the severity of 
the disease (22). Our group has previ-
ously shown that US is an effective 
tool to image the hip region and which 
can be a more sensitive indicator of the 
underlying focus for pain (8-10). In pa-
tients with FMS, pain in the hip region 
can often be diffuse thereby making di-
agnosis of musculoskeletal pathology 
complex.
To date, no imaging studies using US 
have been performed in patient cohorts 
with FMS.
This observational multicentre study 
has shown that there is a low yield of 
definite musculoskeletal abnormalities 
within the hip region in a small cohort 
of FMS patients. Whilst a small number 
had US detected hip effusion, this was 
minimal and not felt to correlate with 
any inflammatory symptoms.
There was clinical over-estimation of 
inflammatory involvement of the soft 
tissues which was not borne out by the 
subsequent US examination. Due to 
the relatively small number of patients 
enrolled in the present study, it is dif-
ficult to draw definite conclusions on 
the prevalence of US findings in FMS 
and to be certain how much these find-
ings may be contributing to some of the 
pain within the hip region in this pa-
tient group. For instance, the quite high 
number of osteophytes detected by US 
can be explained by the mean age of the 
study population, higher than 50 years. 
Moreover, the impact of US findings in 
patients with FMS should be compara-
tively investigated in healthy and dis-
ease controls.
In conclusion, since clinical examina-
tion may generate frequently false-pos-
itive results in patients with FMS, the 
higher specificity of the US findings 
can be used to confirm hip joint and 
peri-articular soft-tissue involvement.
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